Characterization of an inhibitor-resistant enzyme IRT-2 derived from TEM-2 β-lactamase produced by proteus mirabilis strains

Journal of Antimicrobial Chemotherapy

Volumn 38, Issue 2, 1996, Pages 183-191

  Bret, L ^a   Chanal, C ^a   Sirot, D ^a   Labia, R ^b   Sirot, J ^a  

^a UNIVERSITÉ CLERMONT AUVERGNE   (France)

^b CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; BETA LACTAMASE;

AMINO ACID SUBSTITUTION; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ANALYSIS; ESCHERICHIA COLI; NONHUMAN; POINT MUTATION; PROTEUS MIRABILIS;

EID: 0029764094     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/38.2.183     Document Type: Article

References (16)

1. Acar, J. C., Chardon H., Choutet, P., Courvalin, P., Dabernat, H., Drugeon, H. et al. (1995). Antibiogram Committee of the French Society for Microbiology. 1995 Statement Pathologie Biologie 43, 1-VIII
2. Ambler, R. P., Coulson, A. F. N., Frère, J. M., Ghuysen, J. M., Joris, B., Forsman, M. et al. (1991). A standard numbering scheme for the class A βMactamases. Biochemistry Journal 276, 269-70.
3. Belaaouaj, A., Lapoumeroulie, C., Caniça, M. M., Vedel, G., Nevot, P., Krishnamoorthy, R. et al. (1994). Nucleotide sequences of the genes coding for the TEM-like β-lactamases IRT-1 and IRT-2 (formerly called TRI-1 and TRI-2). FEMS Microbiology Letters 120, 75-80.
4. Bingen, E., Boissinot, C., Desjardins, P., Cave, H., Brahimi, N., Lambert-Zechovsky, N. et al. (1993). Arbitrarily primed polymerase chain reaction provides rapid differentiation of Proteus mirabilis isolates from a pédiatric hospital. Journal of Clinical Microbiology 31, 1055-9.
5. Blazquez, J., Baquero, M. R., Canton, R., Alos, I. & Baquero, F. (1993). Characterization of a new TEM-type β-lactamase resistant to clavulanate, sulbactam and tazobactam in a clinical isolate of Escherichia coli. Antimicrobial Agents and Chemotherapy 37, 2059-63.
6. Bret, L., Romaszko, J. P., Henquell, C., Sirot, D., Chanal, C. & Sirot, J. (1994). Detection of inhibitor-resistant TEM-β-lactamases (IRT) by the automated ATB methods. 14th Interdisciplinary Meeting on Anti-Infectious Chemotherapy, Paris, 1994. Abstract 323C16.
7. Brun, T., Pepduzzi, J., Caniça, M. M., Paul, G., Névot, P., Barthélémy, M. et al. (1994). Characterization and amino acid sequence of IRT-4, a novel TEM-type enzyme with a decreased susceptibility to β-lactamase inhibitors. FEMS Microbiology Letters 120, 111-117.
8. Chanal, C., Poupart, M. C., Sirot, D., Labia, R., Sirot, J. & Cluzel, R. (1992). Nucleotide sequences of CAZ-2, CAZ-6 and CAZ-7 β-lactamase genes. Antimicrobial Agents and Chemotherapy 36, 1817-20.
9. Chen, S. T. & Clowes, R. C. (1987). Variations between the nucleotide sequences of Tn 1, Tn2 and Tn3 and expression of β-lactamase in Pseudomonas aeruginosa and Escherichia coli. Journal of Bacteriology 169, 913-6.
10. Goussard, S. & Courvalin, P. (1991). Sequence of the genes blaT-1B and blaT-2. Gene 102, 71-3.
11. Henquell, C., Chanal, C., Sirot, D., Labia, R. & Sirot, J. (1995). Molecular characterization of nine different types of mutants among 107 inhibitor-resistant TEM /Mactamases from clinical isolates of Escherichia coli. Antimicrobial Agents and Chemotherapy 39, 427-30.
12. Labia, R., Andrillon, J. & Le Goffic, F. (1973). Computerized microacidimetric determination of β-lactamase Michaelis-Menten constants. FEBS Letters 33, 42-4.
13. Lemozy, J., Sirot, D., Chanal, C., Hue, C., Labia, R., Dabernat, H. et al. (1995). First characterization of inhibitor-resistant TEM (IRT) β-lactamases in Klebsiella pneumoniae strains. Antimicrobial Agents and Chemotherapy 39, 2580-2.
14. Philippen, A., Arlet, G. & Lagrange, P. H. (1994). Origin and impact of plasmid-mediated extended-spectrum beta-lactamases. European Journal of Clinical Microbiology and Infectious Diseases 13, Suppl. 1, 17-29.
15. Sirot, D., Chanal, C., Henquell, C., Labia, R., Sirot, J. & Cluzel, R. (1994). Clinical isolates of Escherichia coli producing multiple TEM-mutants resistant to β-lactamase inhibitors. Journal of Antimicrobial Chemotherapy 33, 1117-26.
16. Zhou, X. Y., Bordon, F., Sirot, D., Kitzis, M. D. & Gutmann, L. (1994). Emergence of clinical isolates of Escherichia coli producing TEM-1 derivatives or an OXA-1 β-lactamase conferring resistance to β-lactamase-inhibitors. Antimicrobial Agents and Chemotherapy 38, 1085-9.